Since February 15, 2021 a new section has been created: "Inter-American Society of Hypertension Topics" on our website. We will periodically publish featured materials within this section.
We are glad to inform you that as of this year 2021 IASH (Interamerican Society of Hypertension) we are an affiliate member of the prestigious institution ESH (European society of Hypertension).
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people fe and effective vaccines are needed urgently.
View More »
The appointment of Dr. Manuel Velasco, editor-in-chief of the Caracas Medical Gazette, as governor for Venezuela of the Inter-American Hypertension Society, prompts him to take on new challenges, among others […]
View More »
The COVID-19 pandemic has had very important negative health, psychological, social and economic repercussions for individuals, families, communities, countries and for humanity in general. […]
View More »
World Hypertension Day promotes its theme Measure Your Blood Pressure, Control It, Live Longer! With the main goal of increasing accuracy of high blood pressure measurement […]
View More »
Angiotensin-converting enzyme 2 (ACE2), a specific high-affinity angiotensin II-hydrolytic enzyme, is the vector that facilitates cellular entry of SARS-CoV-1 and the novel SARS-CoV-2 coronavirus. SARS-CoV-2, which crossed species barriers to infect humans […]
View More »
A collective century of discoveries establishes the importance of the renin angiotensin aldosterone systemin maintaining blood pressure, fluid volume and electrolyte homeostasis via autocrine […]
View More »
Speakers who will participate in the International Forum on Arterial Hypertension: Dr. Luis Alcocer, Dr. Carlos Ferrario, Dr. José Ramón González Juanatey, Dr. Ernesto Cardona Muñoz.
View Video »
There is pressing urgency to understand the pathogenesis of the severe acute respiratory syndrome coronavirus clade 2 (SARS-CoV-2), which causes the disease COVID-19. SARS-CoV-2 spike (S) […]
Read More »
There is pressing urgency to understand the pathogenesis of the severe acute respiratory syndrome coronavirus clade 2 (SARS-CoV-2), which causes the disease COVID-19. SARS-CoV-2 […]
Read More »
A potential association between the use of angiotensin-receptor blockers (ARBs) and angiotensin-converting–enzyme (ACE) inhibitors and the risk of coronavirus disease 2019 (Covid-19) has not been well studied […]
Read More »
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects host cells following binding with the cell surface ACE2 receptors, thereby leading to coronavirus disease 2019 (COVID-19). SARS-CoV-2 […]
Read More »
Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center, Clinicopathologic Case Series.
Coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome […]
Angiotensin‐converting enzyme‐2 (ACE2) has been established as the functional host receptor for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the virus responsible for the current devastating […]
Read More »